Beta Cat Pharmaceuticals, Inc.
Pharmaceutical company · Houston, Texas, United States
Beta Cat Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2014. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,974 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $2.6 million sold in a notice filed in 2018.
Beta Cat Pharmaceuticals at a glance
What does Beta Cat Pharmaceuticals do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $299,974 in total (2018). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $2.6 million sold (2018).
Frequently asked questions about Beta Cat Pharmaceuticals
Where is Beta Cat Pharmaceuticals headquartered?
Beta Cat Pharmaceuticals, Inc. is headquartered in Houston, Texas, United States.
What does Beta Cat Pharmaceuticals do?
Beta Cat Pharmaceuticals, Inc. is a pharmaceutical company.
When was Beta Cat Pharmaceuticals founded?
The earliest incorporation on record for Beta Cat Pharmaceuticals, Inc. is in 2014, according to public company registers.
Similar companies
- Marker Therapeutics, Inc.Houston, Texas, United States
- 7 Hills Pharma Inc.Houston, Texas, United States
- Decoy Therapeutics Inc.Houston, Texas, United States
- CNS Pharmaceuticals, Inc.Houston, Texas, United States
- Coya Therapeutics, Inc.Houston, Texas, United States
- Aravive, Inc.Houston, Texas, United States
- Moleculin Biotech, Inc.Houston, Texas, United States
- Bellicum Pharmaceuticals, IncHouston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences